Abstract:Combination chemotherapy is frequently used in the clinic for cancer treatment; however, associated adverse effects to normal tissue may limit its therapeutic benefit. Nanoparticle-based drug combination has been shown to mitigate the problems encountered by free drug combination therapy. Our previous studies have shown that the combination of two anticancer drugs, doxorubicin (DOX) and mitomycin C (MMC), produced a synergistic effect against both murine and human breast cancer cells in vitro. DOX and MMC co-loaded polymer-lipid hybrid nanoparticles (DMPLN) bypassed various efflux transporter pumps that confer multidrug resistance and demonstrated enhanced efficacy in breast tumor models. Compared to conventional solution forms, such superior efficacy of DMPLN was attributed to the synchronized pharmacokinetics of DOX and MMC and increased intracellular drug bioavailability within tumor cells enabled by the nanocarrier PLN. To evaluate the pharmacokinetics and bio-distribution of co-administered DOX and MMC in both free solution and nanoparticle forms, a simple and efficient multi-drug analysis method using reverse-phase high performance liquid chromatography (HPLC) was developed. In contrast to previously reported methods that analyzed DOX or MMC individually in the plasma, this new HPLC method is able to simultaneously quantitate DOX, MMC and a major cardio-toxic DOX metabolite, doxorubicinol (DOXol), in various biological matrices (e.g., whole blood, breast tumor, and heart). A dual fluorescent and ultraviolet absorbent probe 4-methylumbelliferone (4-MU) was used as an internal standard (I.S.) for one-step detection of multiple drug analysis with different detection wavelengths. This method was successfully applied to determine the concentrations of DOX and MMC delivered by both nanoparticle and solution approaches in whole blood and various tissues in an orthotopic breast tumor murine model. The analytical method presented is a useful tool for pre-clinical analysis of nanoparticle-based delivery of drug combinations.

Microdialysis as a sampling tool for the chemotherapeutic agent Doxorubicin

Doxorubicin concentrations in bone tumour-relevant tissues after bolus and continuous infusion: a randomized porcine microdialysis study

Methodological issues in microdialysis sampling for pharmacokinetic studies

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice.

Microdialysis: A Technique for Pharmacokinetic-Pharmacodynamic Studies of Oncological Drugs

An approach to determination of the intracellular and extracellular concentrations of doxorubicin for MDR cancer cells

Microdialysis—theoretical background and recent implementation in applied life-sciences

A Sensitive Liquid Chromatography/electrospray Tandem Mass Spectroscopy Method for Simultaneous Quantification of a Disulfide Bond Doxorubicin Conjugation Prodrug and Activated Doxorubicin: Application to Cellular Pharmacokinetic and Catabolism Studies

Rapid Analysis of Anthracycline Antibiotics Doxorubicin and Daunorubicin by Microchip Capillary Electrophoresis

Doxorubicin, doxorubicinol, cardiotoxicity, breast cancer, volumetric absorptive microsampling, LC-MS/MS

Enhancing Doxorubicin Detection: Multiphase Electroextraction for Efficient and Affordable UHPLC–DAD Analysis in Saliva

Electrochemical Sensor for the Evaluation of Doxorubicin from Novel Pharmaceutical Formulations and Serum

Microdialysis: A Real-Time Sampling Technique for More Effective Pharmacokinetic- Pharmacodynamic Studies in Drug Research and

[Detecting Doxorubicin Concentration in KBv200 and KB Cell Xenografts in Nude Mice by High-Performance Liquid Chromatography].

A UPLC-MS/MS method for quantification of a novel doxorubicin conjugation prodrug in tumor cells

Analytical ultracentrifugation for measuring drug distribution of doxorubicin loaded liposomes in human serum

Improved on-tissue detection of the anti-cancer agent doxorubicin by quantitative matrix-assisted laser desorption/ionization mass spectrometry imaging

Study on Relationship Between Transporting Kinetics of Doxorubicin and MDR Reversal Index in K562/A Cells

Optoacoustic properties of Doxorubicin – A pilot study

Voltammetric glassy carbon sensor approach for the extended stability studies of doxorubicin in lyophilized dosage form

Clinical pharmacokinetics of doxorubicin